Page 21

FEATURE

Step

in Diabetes Management

An illustration of the closed-loop insulin delivery system. Depicted on the individual is the glucose sensor, modulator, and the insulin pump.3 References in the spring of 2017. The gap in time between FDA approval and market arises because the FDA prioritized the device’s approval due to its potential to benefit public health. Cost estimates for the device range from $6,000 to $9,000. Psychologically, this will contribute

greatest to ease the burden of living with diabetes, which most commonly requires taking only whole blood samples numerous times a day and either injecting or pumping insulin to level the fluctuations of blood glucose.

1. U.S. Food and Drug Adinistration. PMA P160017: FDA Summary of Safety and Effectiveness Data (SSED). Silver Spring, MD: U.S. Food and Drug Administration; 2016 p. 75. 2. What is the pancreas? What is an artificial pancreas device system? [Internet]. Fda.gov. 2016 [cited 1 October 2016]. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/ConsumerProducts/ArtificialPancreas/ucm259548.htm 3. Elleri D, Dunger D, Hovorka R. Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Medicine. 2011;9(1).

IMS MAGAZINE FALL 2016 ENGINEERING AND MEDICINE | 21

Profile for IMS Magazine

Ims Magazine Fall 2016  

The fall issue of the IMS Magazine for 2016, with a feature on Engineering and Medicine.

Ims Magazine Fall 2016  

The fall issue of the IMS Magazine for 2016, with a feature on Engineering and Medicine.

Advertisement